Literature DB >> 6282752

Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.

A C Issekutz, S Bhimji, R Bortolussi.   

Abstract

Bacterial invasion of the tissues often stimulates a vigorous inflammatory reaction, which may limit the spread of microorganisms but may also be accompanied by serious vascular injury and tissue damage. We previously studied the inflammatory reaction induced by the injection of killed Escherichia coli into rabbit skin, a model suitable for the quantitation of various parameters of inflammation. Here we report the effect of immune serum treatment of the E. coli on their capacity to induce inflammation and vascular injury. Injection of killed E. coli treated with immune serum elicited a reaction which had a smaller increase in vascular permeability (protein exudation), measured with (125)I-labeled albumin, less increase in blood flow, measured with (86)RbCl, less leukocyte infiltration, measured with (51)Cr-labeled leukocytes, and a lesser degree of hemorrhage, measured with (59)Fe-labeled erythrocytes, than E. coli treated with nonimmune serum. Crossover experiments with four different E. coli serotypes and four different antisera indicated that antibody to specific O antigens or a related antigen, but not to K or H antigen, was important for modifying the inflammatory response. Treatment of four different E. coli serotypes with antiserum to "core" glycolipid, produced by immunization with the E. coli J5 mutant, inhibited the inflammatory response to all four E. coli serotypes. Finally, treatment of killed E. coli with polymyxin B also inhibited their inflammation-inducing potential. These results suggest that it may be possible to diminish the magnitude of local vascular and tissue injury associated with E. coli infections by the use of antisera or polymyxin B, which bind to endotoxin on the E. coli.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282752      PMCID: PMC351263          DOI: 10.1128/iai.36.2.548-557.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Regional blood flow to the lymph node during the immune response.

Authors:  P G Herman; D Lyonnet; R Fingerhut; R N Tuttle
Journal:  Lymphology       Date:  1976-09       Impact factor: 1.286

2.  Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.

Authors:  D C Morrison; D M Jacobs
Journal:  Immunochemistry       Date:  1976-10

3.  Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate.

Authors:  J J Corrigan; B M Bell
Journal:  J Lab Clin Med       Date:  1971-05

4.  Structure and biosynthesis of the cell wall lipopolysaccharide of Escherichia coli.

Authors:  E C Heath; R M Mayer; R D Edstrom; C A Beaudreau
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

5.  Prevention by polymyxin B of endotoxin lethality in mice.

Authors:  D Rifkind
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

6.  Simple method for quantitation of enhanced vascular permeability.

Authors:  K Udaka; Y Takeuchi; H Z Movat
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

7.  Neutralization of the Shwartzman reactions by polymyxins B.

Authors:  D Rifkind; R B Hill
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

8.  Rubella 1974 and its aftermath, congenital rubella syndrome.

Authors:  R S Faulkner; D A Gough
Journal:  Can Med Assoc J       Date:  1976-01-24       Impact factor: 8.262

9.  Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.

Authors:  D J Scribner; D Fahrney
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

10.  A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group.

Authors:  G H McCracken; S G Mize
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

View more
  7 in total

1.  Endotoxin-stimulated human macrophages produce a factor that induces polymorphonuclear leucocyte infiltration and is distinct from interleukin-1, tumour necrosis factor alpha and chemotactic factors.

Authors:  P Megyeri; J Sadowska; T B Issekutz; A C Issekutz
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 2.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

3.  Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide.

Authors:  R L Danner; K A Joiner; M Rubin; W H Patterson; N Johnson; K M Ayers; J E Parrillo
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.

Authors:  F R Kohn; A H Kung
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Neutropenic responses to intradermal injections of Escherichia coli. Effects on the kinetics of polymorphonuclear leukocyte emigration.

Authors:  M I Cybulsky; I J Cybulsky; H Z Movat
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation.

Authors:  A G Harmsen
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

7.  Role of interleukin-1 and tumour necrosis factor in leukocyte recruitment to acute dermal inflammation.

Authors:  A C Issekutz; N Lopes; T B Issekutz
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.